CYTRA-K CRYSTALS- potassium citrate and citric acid granule, for solution

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Ingredientes activos:

Potassium Citrate (UNII: EE90ONI6FF) (Anhydrous Citric Acid - UNII:XF417D3PSL), Citric Acid Monohydrate (UNII: 2968PHW8QP) (Anhydrous Citric Acid - UNII:XF417D3PSL)

Disponible desde:

Cypress Pharmaceutical, Inc.

Designación común internacional (DCI):

Potassium Citrate

Composición:

Potassium Citrate 3.3 g

Vía de administración:

ORAL

tipo de receta:

PRESCRIPTION DRUG

indicaciones terapéuticas:

CYTRA-K CRYSTALS is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. CYTRA-K CRYSTALS is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. CYTRA-K CRYSTALS alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. Potassium cit

Resumen del producto:

CYTRA-K CRYSTALS - 100 Packets/box (NDC 60258-005-01). Store at controlled room temperature, 15°-30°C (59°-86°F). Protect from excessive heat or freezing.

Estado de Autorización:

unapproved drug other

Ficha técnica

CYTRA-K CRYSTALS - POTASSIUM CITRATE AND CITRIC ACID GRANULE, FOR
SOLUTION
CYPRESS PHARMACEUTICAL, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
CYTRA-K
CRYSTALS
(POTASSIUM CITRATE AND
CITRIC ACID FOR ORAL SOLUTION)
RX ONLY
NDC 60258-005-01
DESCRIPTION
CYTRA-K CRYSTALS (potassium citrate and citric acid for oral solution)
is a pleasant-tasting oral
systemic alkalizer containing potassium citrate and citric acid in a
sugar-free base.
Each packet of CYTRA-K CRYSTALS, when reconstituted, provides the
following amounts
of active ingredients :
Potassium Citrate Monohydrate
3300 mg
Citric Acid Monohydrate
1002 mg
and provides 30 mEq potassium, equivalent to 30 mEq bicarbonate (HCO
).
INACTIVE INGREDIENTS
Sodium saccharin, fruit punch flavor, and FD&C Red Dye #3.
POTASSIUM CITRATE MONOHYDRATE has the chemical name:
1,2,3-Propanetricarboxylic acid, 2-hydroxy-
,tripotassium salt, monohydrate. Its chemical structure is as follows:
C H K O · H O M.W. 324 .4 1
CITRIC ACID MONOHYDRATE has the chemical name:
1,2,3-Propanetricarboxylic acid, 2-hydroxy-,
monohydrate. Its chemical structure is as follows:
3
6
5
3
7
2
C H O · H O M.W. 210.14
CLINICAL PHARMACOLOGY
Potassium citrate is absorbed and metabolized to potassium
bicarbonate, thus acting as a systemic
alkalizer. The effects are essentially those of chlorides before
absorption and those of bicarbonates
subsequently. Oxidation is virtually complete so that less than 5% of
the potassium citrate is excreted in
the urine unchanged.
INDICATIONS AND USAGE
CYTRA-K CRYSTALS is an effective alkalinizing agent useful in those
conditions where long-term
maintenance of an alkaline urine is desirable, such as in patients
with uric acid and cystine calculi of the
urinary tract, especially when the administration of sodium salts is
undesirable or contraindicated. In
addition, it is a valuable adjuvant when administered with uricosuri